5-chloro-2-methyl-benzophenone | 33184-55-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-chloro-2-methyl-benzophenone
• 英文别名: 5-Chlor-2-methyl-benzophenon；Phenyl-(5-chlor-2-methyl-phenyl)-keton；5-chloro-2-methylbenzophenone；5-chloro-2methylbenzophenone；2-Methyl-5-chloro-benzophenon；5-Chlor-2-methylbenzophenon；(5-Chloro-2-methylphenyl)phenylmethanone；(5-chloro-2-methylphenyl)-phenylmethanone
• CAS: 33184-55-3
• 化学式: C₁₄H₁₁ClO
• 分子量: 230.694
• InChiKey: MEILSOQVXNYFTC-UHFFFAOYSA-N

物化性质

• 熔点：
  41 °C
• 沸点：
  191 °C(Press: 12 Torr)
• 密度：
  1.178±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  5-chloro-2-methyl-benzophenone 在 chromium(VI) oxide 、 硫酸 作用下， 以 溶剂黄146 为溶剂， 生成 2-苯甲酰基-4-氯苯甲酸
  参考文献：
  名称：

  5-Aryl-2,3-dihydro-5H-imidazo[2,1-a]isoindol-5-ols. Novel class of anorectic agents

  摘要：

  A series of 5-aryl-2,3-dihydro-5H-imidazo[2,1-a]isoindol-5-ols (IV), prepared by the LiA1H4 reduction of the corresponding 9b-aryl-1,2,3,9b-tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones (II), was evaluated for suppression of food consumption in rats. One member of this series, 5-p-chlorophenyl-2,3-dihydro-5H-imidazo[2,1-a]isoindol-5-ol (6, mazindol), was evaluated in squirrel and capuchin monkeys and found to have anorexic activity approximately equal to d-amphetamine.

  DOI：

  10.1021/jm00236a014
• 作为产物：
  描述：

  5-氯-2-甲基苯甲酸 在 acid chloride 、 三氯化铝 、 苯 、 ice 、 乙醚 、 sodium hydroxide 、 氯化钠 作用下， 以 氯化亚砜 为溶剂， 反应 17.5h， 以to yield the 5-chloro-2-methylbenzophenone showing in the I.R的产率得到5-chloro-2-methyl-benzophenone
  参考文献：
  名称：

  Pyrazolobenzazepines

  摘要：

  6-芳基-1-或2H，4H-吡唑并[4,3-d]（2）-苯并吲哚啉，例如公式##STR1## R = H或烷基，R.degree. = H，烷基，（HO，烷氧基，氨基）-烷基，芳基甲基，芳基或酰基，R' = h，oh或烷基，R" = h，烷基，烷氧基，卤素或CF.sub.3 N-其氧化物或这些化合物的治疗上有用的酸盐具有抗焦虑和抗抑郁作用。

  公开号：

  US04022801A1

文献信息

• Pyrazolobenzazepines
  申请人：Ciba-Geigy Corporation

  公开号：US03947585A1

  公开（公告）日：1976-03-30

  6-Aryl-1 or 2H,4H-pyrazolo[4,3-d](2)-benzazepines, e.g. those of the formula ##SPC1## R = h or alkyl R.sup.o = H, alkyl, (HO, alkoxy, amino)-alkyl, aralkyl or aryl R' = h, oh or alkyl R" = h, alkyl, alkoxy, halo or CF.sub.3 5,6-dihydro- or 5-alkyl-5,6-dihydro-derivatives, N-oxides, acyl derivatives or therapeutically useful acid addition salts thereof exhibit antianxiety and antidepressant effects.

  6-芳基-1或2H,4H-吡唑并[4,3-d](2)-苯并蒽啶类化合物，例如符合以下公式的化合物：##SPC1## R = h或烷基 R.sup.o = H，烷基，(HO，烷氧基，氨基)-烷基，芳基烷基或芳基 R' = h，oh或烷基 R" = h，烷基，烷氧基，卤素或CF.sub.3 5,6-二氢-或5-烷基-5,6-二氢衍生物，N-氧化物，酰基衍生物或其治疗上有用的酸盐具有抗焦虑和抗抑郁作用。
• 2,4,6-TRIAMINO-1,3,5-TRIAZINE DERIVATIVE
  申请人：Kubota Hideki

  公开号：US20080227785A1

  公开（公告）日：2008-09-18

  This invention relates to an anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient. It was proved that the BEC 1 potassium channel inhibitor has an action to improve learning disorder and is useful as a preventive or therapeutic agent for diseases, preferably dementia, in which the BEC 1 potassium channel is considered to be concerned. Illustratively, it was confirmed by an in vivo test that the BEC 1 potassium channel inhibitor has an action to improve learning disorder. Also, it was found that a compound having 2,4,6-triamino-1,3,5-triazine has a BEC 1 potassium channel inhibitory action.

  本发明涉及一种以BEC 1钾离子通道抑制剂作为活性成分的抗痴呆剂。已经证明，BEC 1钾离子通道抑制剂具有改善学习障碍的作用，并且作为预防或治疗剂是有用的，尤其是对于BEC 1钾离子通道与之相关的疾病，如痴呆症。例如，通过体内试验证实，BEC 1钾离子通道抑制剂具有改善学习障碍的作用。此外，还发现具有2,4,6-三氨基-1,3,5-三嗪的化合物具有BEC 1钾离子通道抑制作用。
• ANTIALLERGIC AGENTS
  申请人：Muto Susumu

  公开号：US20080090779A1

  公开（公告）日：2008-04-17

  A medicament for the preventive and/or therapeutic treatment of allergic diseases and/or endometriosis and/or hysteromyoma which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein X represents a connecting group whose number of atoms in the main chain is 2 to 5 (said connecting group may be substituted), A represents hydrogen atom or acetyl group, E represents an aryl group which may be substituted or a hetero aryl group which may be substituted, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula —O-A wherein A has the same meaning as that defined above and the group represented by formula —X-E wherein each of X and E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula —O-A wherein A has the same meaning as that defined above and the group represented by formula —X-E wherein each of X and E has the same meaning as that defined above.

  一种预防和/或治疗过敏性疾病和/或子宫内膜异位症和/或子宫肌瘤的药物，其包括以下通式（I）所表示的化合物或其药学上可接受的盐、水合物和溶剂化物作为活性成分，其中X表示连接基，其主链中原子数为2至5（该连接基可以被取代），A表示氢原子或乙酰基，E表示芳基或取代的杂芳基，环Z表示苯环，除了由公式-O-A表示的基团，该苯环还可以具有一个或多个取代基团，其中A的含义与上述定义相同，而由公式-X-E表示的基团中，每个X和E的含义也与上述定义相同，或者是一个杂环，除了由公式-O-A表示的基团，该杂环还可以具有一个或多个取代基团，其中A的含义与上述定义相同，而由公式-X-E表示的基团中，每个X和E的含义也与上述定义相同。
• Antiallergic agents
  申请人：Muto Susumu

  公开号：US20070185059A1

  公开（公告）日：2007-08-09

  A medicament for the preventive and/or therapeutic treatment of allergic diseases and/or endometriosis and/or hysteromyoma which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein X represents a connecting group whose number of atoms in the main chain is 2 to (said connecting group may be substituted), A represents hydrogen atom or acetyl group, E represents an aryl group which may be substituted or a hetero aryl group which may be substituted, ring Z represents an arene which may have one or more substitutents in addition to the group represented by formula —O-A wherein A has the same meaning as that defined above and the group represented by formula —X-E wherein each of X and E has the same meaning as that defined above, or a heteroarene which may have one or more substitutents in addition to the group represented by formula —O-A wherein A has the same meaning as that defined above and the group represented by formula —X-E wherein each of X and E has the same meaning as that defined above.

  一种用于预防和/或治疗过敏性疾病和/或子宫内膜异位症和/或子宫肌瘤的药物，其活性成分包括以下通式（I）表示的化合物或其药学上可接受的盐、水合物和溶剂化物中的一种，其中X代表连接基，其主链中的原子数为2到（该连接基可以被取代），A代表氢原子或乙酰基，E代表芳基或取代的杂环芳基，环Z代表芳烃，除了由公式-O-A表示的基团外，还可以有一个或多个取代基，其中A具有上述定义的相同含义，并且由公式-X-E表示的基团，其中X和E的每个都具有上述定义的相同含义，或者可以有一个或多个取代基的杂芳烃，其中A具有上述定义的相同含义，并且由公式-X-E表示的基团，其中X和E的每个都具有上述定义的相同含义。
• Etude sur la chloruration des d�riv�s de l?o-m�thyl-benzoph�none
  作者：Henri De Diesbach、Pierre Dobbelmann

  DOI：10.1002/hlca.19310140134

  日期：——